A Phase 2a Efficacy, Safety, Tolerability, and PK Study of SYT-510 in Participants With Generalized Anxiety Disorder
Clinical trial NCT07478744 · RECRUITING
Trial details
- NCT number
- NCT07478744
- Sponsor
- Synendos Therapeutics AG
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-22
- Primary completion
- 2027-01-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.